Cargando…

SPAR – a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial

BACKGROUND: Retrospective studies show improved outcomes in colorectal cancer patients if taking statins, including overall survival, pathological response of rectal cancer to preoperative chemoradiotherapy (pCRT), and reduced acute and late toxicities of pelvic radiation. Major tumour regression fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jameson, Michael B., Gormly, Kirsten, Espinoza, David, Hague, Wendy, Asghari, Gholamreza, Jeffery, Grahame Mark, Price, Timothy Jay, Karapetis, Christos Stelios, Arendse, Michael, Armstrong, James, Childs, John, Frizelle, Frank A., Ngan, Sam, Stevenson, Andrew, Oostendorp, Martinus, Ackland, Stephen P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918635/ https://www.ncbi.nlm.nih.gov/pubmed/31847830 http://dx.doi.org/10.1186/s12885-019-6405-7

Ejemplares similares

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
por: Mercieca-Bebber, R., et al.
Publicado: (2022)

Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer
por: Sjoquist, Katrin M., et al.
Publicado: (2022)

The Brent Spar saga.
Publicado: (1995)

Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial
por: Tebbutt, N C, et al.
Publicado: (2013)

Sparring and Neurological Function in Professional Boxers
por: Stiller, John W., et al.
Publicado: (2014)

MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)
por: Siu, Ho Wai Derrick, et al.
Publicado: (2021)

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
por: Tebbutt, N C, et al.
Publicado: (2010)

Clustering on longitudinal quality‐of‐life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO.20 trial
por: Zhang, Jiahui, et al.
Publicado: (2022)

FastSpar: rapid and scalable correlation estimation for compositional data
por: Watts, Stephen C, et al.
Publicado: (2019)

INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)
por: Lam, Lyn Ley, et al.
Publicado: (2023)

Resistant Hypertension and Obstructive Sleep Apnea: The Sparring Partners
por: Thomopoulos, Costas, et al.
Publicado: (2011)

Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners?
por: Rigante, Donato, et al.
Publicado: (2015)

The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank
por: Lonie, James M., et al.
Publicado: (2023)

SparSNP: Fast and memory-efficient analysis of all SNPs for phenotype prediction
por: Abraham, Gad, et al.
Publicado: (2012)

TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
por: Leong, Trevor, et al.
Publicado: (2015)

SparX-fel: version 1.00 : scientific case
Publicado: (2009)

SParSE++: improved event-based stochastic parameter search
por: Roh, Min K., et al.
Publicado: (2016)

SPAR: small RNA-seq portal for analysis of sequencing experiments
por: Kuksa, Pavel P, et al.
Publicado: (2018)

Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?
por: Onfroy-Roy, Lauriane, et al.
Publicado: (2021)

VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer
por: Chionh, Fiona, et al.
Publicado: (2022)

Predictive value of chromosome 18q11.2‐q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III‐trial AGITG‐MAX
por: van Dijk, Erik, et al.
Publicado: (2022)

SparX-fel: version 2.00 : Technical design report
Publicado: (2009)

Surgical management of urachal tumors: Can the umbilicus be sparred in localized disease?
por: Pavelescu, Cristian, et al.
Publicado: (2019)

Research on Video Quality Evaluation of Sparring Motion Based on BPNN Perception
por: Changbi, Zhao, et al.
Publicado: (2021)

De-Bonding Numerical Characterization and Detection in Aeronautic Multi-Element Spars
por: Concilio, Antonio, et al.
Publicado: (2022)

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer
por: Goldstein, D, et al.
Publicado: (2012)

Complete Genome of the Attenuated Sparfloxacin-Resistant Streptococcus agalactiae Strain 138spar
por: Pridgeon, Julia W., et al.
Publicado: (2014)

SparRec: An effective matrix completion framework of missing data imputation for GWAS
por: Jiang, Bo, et al.
Publicado: (2016)

Effects of different recovery methods on postboxing sparring fatigue substances and stress hormones
por: Tianlong, Duan, et al.
Publicado: (2019)

Gefühlte Inflation als Bestimmungsgrund der Spar- und Konsumstruktur von Verbrauchern
por: Krämer, Andreas, et al.
Publicado: (2022)

AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer
por: Oar, Andrew, et al.
Publicado: (2021)

AdvISER-PYRO: Amplicon Identification using SparsE Representation of PYROsequencing signal
por: Ambroise, Jérôme, et al.
Publicado: (2013)

Corrigendum: SparRec: An effective matrix completion framework of missing data imputation for GWAS
por: Jiang, Bo, et al.
Publicado: (2016)

Orthopaedic interventions in patients with psoriatic arthritis: a descriptive report from the SPAR cohort
por: Haque, Naba, et al.
Publicado: (2016)

1145. Sparring With Spores: Ultrasounds as a Vector for Pathogen Transmission in the Intensive Care Unit
por: John, Amrita, et al.
Publicado: (2018)

Costs and effectiveness of the supervision, performance assessment and recognition (SPARS) strategy for medicines management in Uganda
por: Kwesiga, Brendan, et al.
Publicado: (2019)

Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial
por: Siou, Kaitlin, et al.
Publicado: (2016)

Erratum to: Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial
por: Siou, Kaitlin, et al.
Publicado: (2017)

Mesenteric SParIng versus extensive mesentereCtomY in primary ileocolic resection for ileocaecal Crohn’s disease (SPICY): study protocol for randomized controlled trial
por: van der Does de Willebois, E M L
Publicado: (2022)

Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)
por: Bardini, Gianluca, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1m071cg3aog012lqu32s1vm6gn